Literature DB >> 26028628

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Bartolome R Celli1, Marc Decramer1, Jadwiga A Wedzicha1, Kevin C Wilson2, Alvar A Agustí1, Gerard J Criner1, William MacNee1, Barry J Make1, Stephen I Rennard1, Robert A Stockley1, Claus Vogelmeier1, Antonio Anzueto1, David H Au1, Peter J Barnes1, Pierre-Regis Burgel1, Peter M Calverley1, Ciro Casanova1, Enrico M Clini1, Christopher B Cooper1, Harvey O Coxson1, Daniel J Dusser1, Leonardo M Fabbri1, Bonnie Fahy1, Gary T Ferguson1, Andrew Fisher1, Monica J Fletcher1, Maurice Hayot1, John R Hurst1, Paul W Jones1, Donald A Mahler1, François Maltais1, David M Mannino1, Fernando J Martinez1, Marc Miravitlles1, Paula M Meek1, Alberto Papi1, Klaus F Rabe1, Nicolas Roche1, Frank C Sciurba1, Sanjay Sethi1, Nikos Siafakas1, Don D Sin1, Joan B Soriano1, James K Stoller1, Donald P Tashkin1, Thierry Troosters1, Geert M Verleden1, Johny Verschakelen1, Jorgen Vestbo1, John W Walsh1, George R Washko1, Robert A Wise1, Emiel F M Wouters1, Richard L ZuWallack1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) Research Statement is to describe evidence related to diagnosis, assessment, and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers and patient advocates believe will have the greatest impact on patient-centred outcomes.
Copyright ©ATS/ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26028628     DOI: 10.1183/16000617.00000315

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  19 in total

1.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

2.  Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen.

Authors:  E Charbek; K Huynh; E Kim; R P Nayak
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  Diagnosis of Chronic Obstructive Pulmonary Disease: Breathing New Life into an Old Debate.

Authors:  Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2018-02

4.  Time to Exhale: Additional Value of Expiratory Chest CT in Chronic Obstructive Pulmonary Disease.

Authors:  Joshua Gawlitza; Frederik Trinkmann; Hans Scheffel; Andreas Fischer; John W Nance; Claudia Henzler; Nils Vogler; Joachim Saur; Ibrahim Akin; Martin Borggrefe; Stefan O Schoenberg; Thomas Henzler
Journal:  Can Respir J       Date:  2018-03-04       Impact factor: 2.409

5.  Physiological and biological characterization of smokers with and without COPD.

Authors:  Nveed Chaudhary; Karsta Luettich; Michael J Peck; Elena Pierri; Loyse Felber-Medlin; Gregory Vuillaume; Patrice Leroy; Julia Hoeng; Manuel C Peitsch
Journal:  F1000Res       Date:  2017-06-13

6.  The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Kristina Vermeersch; Maria Gabrovska; Griet Deslypere; Ingel K Demedts; Hans Slabbynck; Joseph Aumann; Vincent Ninane; Geert M Verleden; Thierry Troosters; Kris Bogaerts; Guy G Brusselle; Wim Janssens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-31

7.  Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Miguel Santibáñez; Roberto Garrastazu; Mario Ruiz-Nuñez; Jose Manuel Helguera; Sandra Arenal; Cristina Bonnardeux; Carlos León; Juan Luis García-Rivero
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

8.  Magnitude of exercise capacity and quality of life improvement following repeat pulmonary rehabilitation in patients with COPD.

Authors:  Jacqueline S Sandoz; Mary M Roberts; Jin-Gun Cho; John R Wheatley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-06

9.  Airway Epithelial Cell Function and Respiratory Host Defense in Chronic Obstructive Pulmonary Disease.

Authors:  Gimano D Amatngalim; Pieter S Hiemstra
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

10.  Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.

Authors:  Dhvani Shah; Maurice Driessen; Nancy Risebrough; Timothy Baker; Ian Naya; Andrew Briggs; Afisi S Ismaila
Journal:  Cost Eff Resour Alloc       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.